Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Aptose Biosciences Inc. (T.APS) had Normalized Income after Taxes of -9.74M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-9.74M |
|
-- |
|
-- |
|
-- |
|
-9.57M |
|
-- |
|
-9.74M |
|
-9.74M |
|
-9.74M |
|
-9.74M |
|
-9.74M |
|
|
Normalized Income after Taxes |
-9.74M |
-9.57M |
|
-9.44M |
|
2.55M |
|
2.55M |
|
-3.82 |
|
-3.82 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
7.73M |
|
-- |
|
-- |
|
-- |
|
27.61M |
|
-19.88M |
|
-19.88M |
|
-19.88M |
|
2.55M |
|
| Cash Flow Statement Financials | |
-12.09M |
|
-- |
|
4.61M |
|
9.28M |
|
1.80M |
|
-7.48M |
|
0.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.36 |
|
-- |
|
-- |
|
-- |
|
-0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
49.01% |
|
49.01% |
|
-125.97% |
|
49.01% |
|
-7.79 |
|
-4.74 |
|
-4.74 |
|